MedTrace Logo

Myopia Control by Combining Auricular Acupoint and Atropine Eyedrops

NCT00457717 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 60

Last updated 2007-04-06

No results posted yet for this study

Summary

This study was designed to compare the difference of using atropine eyedrops alone from atropine combined with the stimulation of auricular acupoints therapy in reducing myopia progression.

Conditions

  • Myopia

Interventions

DRUG

0.25 % atropine

DRUG

0.5 % atropine

PROCEDURE

0.25 % atropine+auricular acupoints

Sponsors & Collaborators

  • China Medical University, China

    lead OTHER

Principal Investigators

  • Shih-Liang Chang, PhD · China Medical University, Taiwan

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
6 Years
Max Age
15 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2005-07-31
Completion
2006-07-31

Countries

  • Taiwan

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00457717 on ClinicalTrials.gov